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The Academic Medical Center opened in 1980 and
replaced the old pavilion hospitals with separated depart-
ments inside Amsterdam. Since that time the concept of
a multidisciplinary approach for patients with gastro-
intestinal disorders, and in particular hepatobiliary and
pancreatic diseases, has been developed. This approach
started with a strong interest in the non-surgical treatment
of HPB diseases by the endoscopic route and stenting
developed by Drs Kee S Huibregtse and Guido Tytgat [1,2].
The former chairman of the Department of Surgery, Dr
Niels van der Heyde, added the expertise of the surgical
approach. His main interest was the surgical treatment and
effect of radiotherapy for proximal bile duct tumours
(Klatskin tumours) [3,4]. Drs Huug Obertop (chairman of
the Department of Surgery) and Dirk Gouma were appoint-
ed in 1993. Together with Dr Thomas van Gulik (head of
Experimental Surgery), and Dr Olivier Busch, they lead
the ‘surgical’ programme of HPB disorders.
The AMC is a tertiary referral center for HPB diseases
in the Netherlands as well as providing a general service for
the local community. An important binding factor in the
clinical programme as a referral centre is the twice-weekly
multidisciplinary HPB meeting. The referral and multidis-
ciplinary management of 250 patients with bile duct
injuries after laparoscopic cholecystectomy during the past
years emphasises this function [5,6]. Gallstone formation
and the surgical and non-surgical management of sympto-
matic gallstone disease have also been studied extensively
by the departments of Surgery and Gastroenterology [7–9].
During the past decade several aspects of the manage-
ment of HPB malignancies have been studied, again by co-
operation of different departments. The value of diagnostic
laparoscopy and other diagnostic modalities such as
endosonography, ultrasound and spiral CT-scan, preopera-
tive biliary drainage and perioperative feeding are analysed
in different studies [10–14]. The role of systemic inflamma-
tion and cytokine release in obstructive jaundice and bil-
iary drainage have been analysed in detail [15,16]. The
non-operative approach of (benign and malignant) HPB
diseases is strongly stimulated by the gastroenterologists
and the new team of radiologists (Dr Han Lameris, chair-
man) [2,5,8,17]. The results of the pylorus-preserving
pancreatoduodenectomy and aspects of centralisation are
studied in data from the AMC and the whole of the
Netherlands [18]. Together with the Department of
Pathology (Drs Fiebo ten Kate and Johan Offerhaus) the
prognostic role of diagnostic markers in bile duct and
pancreatic carcinoma has been investigated [19,20]. Effects
of chemoradiotherapy in pancreatic carcinoma and radio-
therapy in proximal bile duct tumours are studied in col-
laboration with the Department of Medical Oncology and
Radiotherapy (Drs Gonzalez and Van Tienhoven).
Finally within the liver programme, the current studies
include the ischaemia-reperfusion phenomenon after liver
resection, the effect of extrahepatic cholestasis on liver
regeneration, continuous or intermittent vascular inflow
occlusion during resection and a new bioartificial liver
(BAL) [23,24,25, 26]. The development of adenoviral gene
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therapy was initiated recently in a new multidisciplinary
research programme. The multidisciplinary approach to
patient care has improved the quality of care, as has the
combination of clinical and fundamental research by the
different members of our HPB team (Figure 1).
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